| ★ | Enlicitide Receives FDA Approval for Hypercholesterolemia Following CORALreef Trials | | 681 | Estados Unidos | |
| 20 | Furoscix ReadyFlow (Furosemide) and its Impact on HF, CKD Edema Treatment | | 374 | Estados Unidos | 64 |
| 3 | Highlighting FDA-Approved Therapies in Atopic Dermatitis, With Chris Bunick, MD, PhD | | 152 | Estados Unidos | 69 |
| 14 | Phase 3b ENCORE: ALIS Improves MAC Lung Disease Outcomes | ATS 2026 | | 117 | Estados Unidos | 64 |
| 1 | How Does the FDA Approval of Risankizumab Impact Pediatric Psoriasis and PsA? With Amy Paller, MD | | 109 | Estados Unidos | 76 |
| 19 | Ruxolitinib, Tapinarof, Roflumilast: What's New for Pediatric AD | | 102 | Estados Unidos | 64 |
| 2 | PROACTIVE-HF: Cordella PA Sensor Improves HF Status Regardless of EF | | 100 | Estados Unidos | 69 |
| 10 | VESALIUS-CV: Evolocumab Prevents Cardiovascular Disease in High-Risk Diabetes | | 96 | Estados Unidos | 65 |
| 7 | CALIBRATE: Encaleret Achieves Mineral Homeostasis in Patients With ADH1, With Rachel Gafni, MD | | 88 | Estados Unidos | 67 |
| 11 | Juana Hutchinson-Colas, MD, OB/GYN | RWJBarnabas Health @rwjbarnabashealth | 86 | Estados Unidos | 65 |
| 17 | MAESTRO-NASH: Resmetirom May Reduce Cardiovascular Risk in MASH, With or Without Statins | | 86 | Estados Unidos | 64 |
| 5 | SUNRISE: Tezepelumab Shows Meaningful OCS Reduction in Severe Asthma | | 78 | Estados Unidos | 69 |
| 16 | Tezepelumab Cuts Severe Asthma Exacerbations 70% in Real-World Patients | ATS 2026 | | 68 | Estados Unidos | 64 |
| 4 | Crinecerfont Enables Sustained Glucocorticoid Dose Reductions Through 2 Years in Adults With CAH | | 67 | Estados Unidos | 69 |
| 15 | Omalizumab vs Oral Immunotherapy for Multifood Allergy | | 65 | Estados Unidos | 64 |
| 6 | Implications of the Phase 4 Trial of Metreleptin in Patients With General Lipodystrophy | | 55 | Estados Unidos | 68 |
| 18 | APPs Uniquely Positioned in ILD Collaborative Care | | 31 | Estados Unidos | 64 |
| 8 | Key Non-Medication Clinical Pearls for Dermatologists, With Matthew Zirwas, MD | | 21 | Estados Unidos | 66 |
| 9 | ACC Statement Examines Frailty, Cognitive Impairment, in Cardiovascular Disease | | 17 | Estados Unidos | 66 |
| 12 | Trials and Guidelines Shaping Critical Care, With Rhea Votipka, NP | | 17 | Estados Unidos | 65 |
| 13 | What's Next for Peanut Allergy Microneedle Immunotherapy, With Brian Vickery, MD | | 12 | Estados Unidos | 65 |